The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(4-(1H-Tetrazol-5-yl)phenoxy)butyl)-3,7-dimethyl-3,7-dihydro-1H-Purine-2,6-dione ID: ALA4761400
PubChem CID: 162659248
Max Phase: Preclinical
Molecular Formula: C18H20N8O3
Molecular Weight: 396.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cnc2c1c(=O)n(CCCCOc1ccc(-c3nnn[nH]3)cc1)c(=O)n2C
Standard InChI: InChI=1S/C18H20N8O3/c1-24-11-19-16-14(24)17(27)26(18(28)25(16)2)9-3-4-10-29-13-7-5-12(6-8-13)15-20-22-23-21-15/h5-8,11H,3-4,9-10H2,1-2H3,(H,20,21,22,23)
Standard InChI Key: QJJKIHLIIYCLCY-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
6.3272 -7.9021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8460 -7.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3251 -6.5797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1027 -6.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8111 -6.4234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5209 -6.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5222 -7.6480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8138 -8.0578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1040 -7.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2252 -6.4211 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8151 -8.8750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0779 -8.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8098 -5.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2278 -8.0555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9147 -7.6111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6430 -7.9781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3257 -7.5337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0539 -7.9050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7663 -7.5028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7702 -6.6820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4826 -6.2798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1872 -6.6941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1835 -7.5108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4711 -7.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9876 -5.4760 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7900 -5.3137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1924 -6.0220 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6409 -6.6269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8954 -6.2916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
1 9 1 0
4 9 2 0
6 10 2 0
8 11 2 0
1 12 1 0
5 13 1 0
14 15 1 0
15 16 1 0
16 17 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
18 19 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
25 29 1 0
22 29 1 0
17 18 1 0
7 14 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.41Molecular Weight (Monoisotopic): 396.1658AlogP: 0.47#Rotatable Bonds: 7Polar Surface Area: 125.51Molecular Species: ACIDHBA: 10HBD: 1#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.33CX Basic pKa: ┄CX LogP: 0.96CX LogD: -0.64Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.45Np Likeness Score: -1.64
References 1. Shekouhy M,Karimian S,Moaddeli A,Faghih Z,Delshad Y,Khalafi-Nezhad A. (2020) The synthesis and biological evaluation of nucleobases/tetrazole hybrid compounds: A new class of phosphodiesterase type 3 (PDE3) inhibitors., 28 (12): [PMID:32503691 ] [10.1016/j.bmc.2020.115540 ]